All employers

Teva Pharmaceutical Industries

Details

  • Number of employees
    10000+
  • Company Type
    Large Multi-national
About Teva Pharmaceutical Industries

Teva Pharmaceutical Industries is a global leader in the pharmaceutical industry, dedicated to improving the health and well-being of patients worldwide. Founded in 1901, the company has grown to become one of the largest generic drug manufacturers, providing high-quality medications at affordable prices.

With a strong commitment to innovation, Teva invests significantly in research and development to create new therapies that address unmet medical needs. The company’s extensive portfolio includes a wide range of therapeutic areas, such as central nervous system disorders, respiratory diseases, oncology, and more.

Teva operates in over 60 countries, with a diverse workforce that reflects its global presence. The company’s headquarters are located in Petah Tikva, Israel, but it has a significant operational footprint in the UK, where it contributes to the local economy and healthcare system.

In addition to its generic products, Teva is also known for its specialty medicines, which are developed through advanced technologies and scientific expertise. The company aims to enhance patient access to essential medications while maintaining the highest standards of quality and safety.

Teva’s vision is to be a trusted partner in healthcare, working collaboratively with healthcare professionals, patients, and stakeholders to deliver innovative solutions. The company is committed to sustainability and corporate responsibility, striving to make a positive impact on communities and the environment.

  • Core Values: Integrity, Innovation, and Patient-Centricity
  • Global Reach: Operations in over 60 countries
  • Therapeutic Areas: CNS, Respiratory, Oncology, and more

Through its dedication to excellence and a patient-first approach, Teva Pharmaceutical Industries continues to lead the way in transforming healthcare and improving lives around the globe.

>